Serotonin Transporters in Alcoholism
NCT00085865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2008-03-04
Summary
This study will compare serotonin transporter proteins in people with alcoholism and healthy volunteers to examine how these proteins may be related to the inability of people with alcoholism to appropriately regulate their alcohol consumption. Serotonin transporters regulate levels of the brain chemical serotonin. Problems in this regulation have been implicated in alcoholism.
Healthy normal volunteers and people who suffer from alcoholism who are between 18 and 75 years of age may be eligible for this study. Candidates are screened with a medical history and physical examination, psychiatric diagnostic interview, blood and urine tests, an electrocardiogram, urine toxicology screen, and written psychological evaluations.
Participants undergo positron emission tomography (PET) and magnetic resonance imaging (MRI) scanning to measure serotonin transporter levels in the brain.
PET uses small amounts of a radioactive chemical called a tracer that "labels" the serotonin transporters in the brain. The tracer used in this study is \[11C\]DASB. For the procedure, the subject lies on the scanner bed. A special mask is fitted to the head and attached to the bed to help keep the subject's head still during the scan so the images will be clear. A brief scan is done just before the radioactive tracer is injected. This scan provides measures of the brain that will help in the precise calculation of information from subsequent scans. After the tracer is injected through a catheter (plastic tube) placed in the arm, pictures are taken for about 2 hours.
MRI uses a magnetic field and radio waves to produce pictures of brain structure. The subject lies on a bed that slides into the tube-like scanner, wearing earplugs to muffle loud noises the machine makes when the magnetic fields are switched. The scan takes about an hour, during which time the subject can communicate with the technician.
Conditions
- Alcoholism
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-06-30
- Completion
- 2006-07-31
Countries
- United States
Study Locations
More Related Trials
-
Imaging Cannabinoid CB1 Receptors in Alcohol Dependence
NCT00816439 ·Status: COMPLETED
-
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
NCT06795581 ·Status: RECRUITING ·Phase: PHASE1
-
Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors
NCT01625611 ·Status: COMPLETED ·Phase: PHASE1
-
From Uncomplicated Alcoholism to Korsakoff's Syndrome
NCT01455207 ·Status: UNKNOWN ·Phase: NA
-
[C-11]PiB PET Imaging in Alcohol Use Disorders
NCT03746366 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ketamine/Placebo Family History Positive Study
NCT00588952 ·Status: COMPLETED ·Phase: NA
-
EtOH Interaction Study
NCT00887367 ·Status: COMPLETED ·Phase: PHASE1
-
Alcohol, Behavior, and Brain Imaging
NCT03930446 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism
NCT02262026 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine Alcohol (in Treatment-Resistant Depression)
NCT02122562 ·Status: RECRUITING ·Phase: PHASE2
-
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
NCT05957159 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics
NCT01657760 ·Status: COMPLETED ·Phase: PHASE1
-
The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.
NCT00230425 ·Status: COMPLETED
-
Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)
NCT00249405 ·Status: COMPLETED ·Phase: PHASE2
-
Matching Genotypes and Serotonergic Medications for Alcoholism
NCT01113164 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the BDNF-Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal
NCT02146963 ·Status: COMPLETED
-
Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder Via Microbiota Investigations: A Pilot Study
NCT03152760 ·Status: COMPLETED
-
Neural Mechanisms of Disulfiram Effects
NCT02735577 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
NCT07027839 ·Status: RECRUITING ·Phase: PHASE1
-
Cerebellar Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Alcohol Use Disorder
NCT03829761 ·Status: COMPLETED ·Phase: NA
-
Multimodal Neuroimaging of Alcohol Cues, Cortisol Response, and Compulsive Motivation
NCT04412824 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Retinal Function Using Electroretinogram in Regular Alcohol Users
NCT03818971 ·Status: COMPLETED ·Phase: NA
-
Multisensory Processing of Alcohol Cues in Young Adult Binge Drinkers
NCT06885190 ·Status: NOT_YET_RECRUITING
-
Cerebellar Involvement in Alcohol Use Disorder (AUD)
NCT05732207 ·Status: RECRUITING ·Phase: NA